Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Changes in glucose metabolism in people with different glucose metabolism disorders at baseline: follow-up results of a Finnish national diabetes prevention programme.

Rautio N, Jokelainen J, Oksa H, Saaristo T, Peltonen M, Puolijoki H, Tuomilehto J, Vanhala M, Moilanen L, Uusitupa M, Keinänen-Kiukaanniemi S.

Diabet Med. 2015 Apr 10. doi: 10.1111/dme.12776. [Epub ahead of print]

PMID:
25864699
2.

National diabetes prevention program (DEHKO): awareness and self-reported lifestyle changes in Finnish middle-aged population.

Wikström K, Lindström J, Tuomilehto J, Saaristo TE, Helakorpi S, Korpi-Hyövälti E, Oksa H, Vanhala M, Keinänen-Kiukaanniemi S, Uusitupa M, Peltonen M.

Public Health. 2015 Mar;129(3):210-7. doi: 10.1016/j.puhe.2014.12.019. Epub 2015 Feb 26.

PMID:
25726122
3.

Metabolic signatures of adiposity in young adults: Mendelian randomization analysis and effects of weight change.

Würtz P, Wang Q, Kangas AJ, Richmond RC, Skarp J, Tiainen M, Tynkkynen T, Soininen P, Havulinna AS, Kaakinen M, Viikari JS, Savolainen MJ, Kähönen M, Lehtimäki T, Männistö S, Blankenberg S, Zeller T, Laitinen J, Pouta A, Mäntyselkä P, Vanhala M, Elliott P, Pietiläinen KH, Ripatti S, Salomaa V, Raitakari OT, Järvelin MR, Smith GD, Ala-Korpela M.

PLoS Med. 2014 Dec 9;11(12):e1001765. doi: 10.1371/journal.pmed.1001765. eCollection 2014 Dec.

4.

Serum ferritin levels and the development of metabolic syndrome and its components: a 6.5-year follow-up study.

Hämäläinen P, Saltevo J, Kautiainen H, Mäntyselkä P, Vanhala M.

Diabetol Metab Syndr. 2014 Oct 26;6(1):114. doi: 10.1186/1758-5996-6-114. eCollection 2014.

5.

Cardiometabolic risk factors in patients referred to depression nurse case managers.

Koponen H, Kautiainen H, Leppänen E, Mäntyselkä P, Vanhala M.

Nord J Psychiatry. 2014 Nov 3:1-6. [Epub ahead of print]

PMID:
25363212
6.

Association of serum 25-hydroxyvitamin D with lifestyle factors and metabolic and cardiovascular disease markers: population-based cross-sectional study (FIN-D2D).

Miettinen ME, Kinnunen L, Leiviskä J, Keinänen-Kiukaanniemi S, Korpi-Hyövälti E, Niskanen L, Oksa H, Saaristo T, Tuomilehto J, Vanhala M, Uusitupa M, Peltonen M.

PLoS One. 2014 Jul 7;9(7):e100235. doi: 10.1371/journal.pone.0100235. eCollection 2014.

7.

[Depression and diet ].

Seppälä J, Kauppinen A, Kautiainen H, Vanhala M, Koponen H.

Duodecim. 2014;130(9):902-9. Review. Finnish.

PMID:
24881142
8.

Lifestyle intervention in prevention of type 2 diabetes in women with a history of gestational diabetes mellitus: one-year results of the FIN-D2D project.

Rautio N, Jokelainen J, Korpi-Hyövälti E, Oksa H, Saaristo T, Peltonen M, Moilanen L, Vanhala M, Uusitupa M, Tuomilehto J, Keinänen-Kiukaanniemi S.

J Womens Health (Larchmt). 2014 Jun;23(6):506-12. doi: 10.1089/jwh.2013.4520. Epub 2014 May 1.

PMID:
24787505
9.

Physical activity and aerobic fitness are positively associated with heart rate variability in obese adults.

Kaikkonen KM, Korpelainen RI, Tulppo MP, Kaikkonen HS, Vanhala ML, Kallio MA, Keinänen-Kiukaanniemi SM, Korpelainen JT.

J Phys Act Health. 2014 Nov;11(8):1614-21. doi: 10.1123/jpah.2012-0405. Epub 2014 Feb 5.

PMID:
24508687
10.

Cross-sectional and longitudinal associations of circulating omega-3 and omega-6 fatty acids with lipoprotein particle concentrations and sizes: population-based cohort study with 6-year follow-up.

Mäntyselkä P, Niskanen L, Kautiainen H, Saltevo J, Würtz P, Soininen P, Kangas AJ, Ala-Korpela M, Vanhala M.

Lipids Health Dis. 2014 Feb 7;13:28. doi: 10.1186/1476-511X-13-28.

11.

Changes in lifestyle modestly reduce the estimated cardiovascular disease risk in one-year follow-up of the Finnish diabetes prevention program (FIN-D2D).

Rautio N, Jokelainen J, Pölönen A, Oksa H, Peltonen M, Vanhala M, Puolijoki H, Moilanen L, Tuomilehto J, Uusitupa M, Keinänen-Kiukaanniemi S, Saaristo T.

Eur J Cardiovasc Nurs. 2015 Apr;14(2):145-52. doi: 10.1177/1474515114521713. Epub 2014 Jan 22.

PMID:
24452452
12.

Consumption of medical resources and outcome of shoulder disorders in primary health care consulters.

Paloneva J, Koskela S, Kautiainen H, Vanhala M, Kiviranta I.

BMC Musculoskelet Disord. 2013 Dec 13;14:348. doi: 10.1186/1471-2474-14-348.

13.

Do depressive symptoms have an impact on the effectiveness of lifestyle counseling in prevention of type 2 diabetes? One-year follow-up of FIN-D2D.

Rautio N, Jokelainen J, Oksa H, Saaristo T, Moilanen L, Vanhala M, Peltonen M, Korpi-Hyövälti E, Tuomilehto J, Uusitupa M, Timonen M, Keinänen-Kiukaanniemi S.

Prim Care Diabetes. 2014 Apr;8(1):43-7. doi: 10.1016/j.pcd.2013.10.005. Epub 2013 Nov 14.

PMID:
24238822
14.

Predictors of success of a lifestyle intervention in relation to weight loss and improvement in glucose tolerance among individuals at high risk for type 2 diabetes: the FIN-D2D project.

Rautio N, Jokelainen J, Saaristo T, Oksa H, Keinänen-Kiukaanniemi S; FIN-D2D Writing Group, Peltonen M, Vanhala M, Korpi-Hyövälti E, Moilanen L, Saltevo J, Niskanen L, Tuomilehto J, Uusitupa M.

J Prim Care Community Health. 2013 Jan;4(1):59-66. doi: 10.1177/2150131912444130. Epub 2012 May 14.

PMID:
23799691
15.

Association between vitamin b12 levels and melancholic depressive symptoms: a Finnish population-based study.

Seppälä J, Koponen H, Kautiainen H, Eriksson JG, Kampman O, Leiviskä J, Männistö S, Mäntyselkä P, Oksa H, Ovaskainen Y, Viikki M, Vanhala M, Seppälä J.

BMC Psychiatry. 2013 May 24;13:145. doi: 10.1186/1471-244X-13-145.

16.

Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

Chan KH, O'Connell RL, Sullivan DR, Hoffmann LS, Rajamani K, Whiting M, Donoghoe MW, Vanhala M, Hamer A, Yu B, Stocker R, Ng MK, Keech AC; FIELD Study Investigators.

Diabetologia. 2013 Apr;56(4):724-36. doi: 10.1007/s00125-012-2818-4. Epub 2013 Jan 17.

PMID:
23322233
17.

Associations of chronotype and sleep with cardiovascular diseases and type 2 diabetes.

Merikanto I, Lahti T, Puolijoki H, Vanhala M, Peltonen M, Laatikainen T, Vartiainen E, Salomaa V, Kronholm E, Partonen T.

Chronobiol Int. 2013 May;30(4):470-7. doi: 10.3109/07420528.2012.741171. Epub 2013 Jan 2.

PMID:
23281716
18.

Long-term leisure-time physical activity and serum metabolome.

Kujala UM, Mäkinen VP, Heinonen I, Soininen P, Kangas AJ, Leskinen TH, Rahkila P, Würtz P, Kovanen V, Cheng S, Sipilä S, Hirvensalo M, Telama R, Tammelin T, Savolainen MJ, Pouta A, O'Reilly PF, Mäntyselkä P, Viikari J, Kähönen M, Lehtimäki T, Elliott P, Vanhala MJ, Raitakari OT, Järvelin MR, Kaprio J, Kainulainen H, Ala-Korpela M.

Circulation. 2013 Jan 22;127(3):340-8. doi: 10.1161/CIRCULATIONAHA.112.105551. Epub 2012 Dec 20.

19.

Perceived sufficiency of physical activity levels among adults at high risk of type 2 diabetes: the FIN-D2D study.

Vähäsarja K, Salmela S, Villberg J, Rintala P, Vanhala M, Saaristo T, Peltonen M, Keinänen-Kiukaanniemi S, Korpi-Hyövälti E, Moilanen L, Niskanen L, Oksa H, Poskiparta ME.

Int J Behav Med. 2014 Feb;21(1):99-108. doi: 10.1007/s12529-012-9285-7.

PMID:
23224617
20.

Erythropoietin, ferritin, haptoglobin, hemoglobin and transferrin receptor in metabolic syndrome: a case control study.

Hämäläinen P, Saltevo J, Kautiainen H, Mäntyselkä P, Vanhala M.

Cardiovasc Diabetol. 2012 Sep 27;11:116. doi: 10.1186/1475-2840-11-116.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk